Lv1
60 积分 2026-01-23 加入
Phase III Data Support Chemo-Free Approach to ALL
3个月前
已关闭
Phase III Data Support Chemo-Free Approach to ALL
3个月前
已关闭
Sustained Benefit of Blinatumomab in Infants With KMT2A -Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics
3个月前
已关闭
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
3个月前
已完结